Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Estrogen-progestin agents]

C Quereux1

  • 1CHU Reims.

Contraception, Fertilite, Sexualite (1992)
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Modern oral contraceptives have evolved with lower ethinylestradiol doses and new progestins, reducing cardiovascular risks and improving metabolic tolerance. This review covers French market products and offers guidance on prescribing and monitoring estroprogestative contraception.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[How did I contract human Papillomavirus (HPV)?].

Gynecologie, obstetrique & fertilite·2010
Same author

[Cervical screening: toward a new paradigm?].

Journal de gynecologie, obstetrique et biologie de la reproduction·2010
Same author

[Oral contraceptives and non-oral contraceptives: realities].

Journal de gynecologie, obstetrique et biologie de la reproduction·2009
Same author

[Hysteroscopic sterilization with Essure: recent findings].

Journal de gynecologie, obstetrique et biologie de la reproduction·2009
Same author

[Difficult contraceptions].

Journal de gynecologie, obstetrique et biologie de la reproduction·2009
Same author

[Pregnancy after uterine-artery embolization for symptomatic fibroids: a case of placenta accreta with uterine rupture].

Journal de gynecologie, obstetrique et biologie de la reproduction·2008
Same journal

[Inflammatory and/or locally advanced breast cancers. Difficulty evaluating the response to initial chemotherapy].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Proximal tubal unblocking by selective salpingography, apropos of 8 cases].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Anatomoclinical correlations of endometriosis].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Effects of raloxifene on bone loss and fracture risk in the menopausal woman].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Cytological screening of uterine cervical cancer by samples in liquid medium (CytoRich). Preliminary study of a series of 111 292 patients].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Diabetes before pregnancy, apropos of 143 cases].

Contraception, fertilite, sexualite (1992)·2000
See all related articles

Area of Science:

  • Reproductive Endocrinology
  • Pharmacology
  • Cardiovascular Medicine

Context:

  • Estroprogestative oral contraceptives have historically been associated with cardiovascular risks.
  • Significant advancements in oral contraceptive formulations have occurred.
  • The French market offers various estroprogestative products.

Purpose:

  • To review the evolution of oral contraceptives, focusing on changes in estroprogestative formulations.
  • To detail the impact of these changes on cardiovascular pathology and metabolic tolerance.
  • To provide practical advice for the prescription and supervision of estroprogestative contraception.

Summary:

  • Oral contraceptives have evolved through reduced ethinylestradiol posology and the incorporation of new progestins.

Related Experiment Videos

  • These modifications have led to a decreased thromboembolic risk and enhanced metabolic tolerance.
  • The review includes an inventory of available products on the French market.

    • Impact:

    • The evolution of oral contraceptives has improved safety profiles, particularly regarding cardiovascular risks.
    • Enhanced metabolic tolerance contributes to better patient adherence and long-term health outcomes.
    • This work provides essential guidance for healthcare professionals prescribing and managing estroprogestative contraception.